Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Alicante
Clinical trial register · Spain

Clinical Trials in Alicante, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Janssen Research & Development, LLC15 AstraZeneca15 Fundación GECP14 Fundación EPIC10 Incyte Corporation8
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Alicante

273 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
Puma Biotechnology, Inc.
Phase 2
50
Alicante, Barcelona, Logroño, Murcia, San Sebastián de los Reyes, Seville
2026-09-17
Not yet open
Fundación GECP
Phase 2
68
Alicante, Elche, Badalona, Barcelona, L'Hospitalet de Llobregat, Granada, Santiago de Compostela, Lugo
2026-09-15
Recruiting
Incyte Corporation
Phase 3
426
Alicante, Barcelona, Bilbao, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Majadahonda, Málaga
2026-09-08
Not yet open
Linzagolix in Adenomyosis and Recurrent Implantation Failure
NCT07698561Adenomyosis of Uterus, Implantation Failure, Infertility Female, Embryo Transfer
Vida Fertility Institute
Observational
35
Alicante, San Sebastián, Madrid
2026-09-01
Not yet open
POST CATARACT SURGERY DRY EYE DISEASE
NCT07715266Dry Eye Disease (DED), Cataract Surgery
NOXELIS
Not applicable
33
Alicante, Valladolid
2026-09
Not yet open
Graft Type and Outcomes After ACL Reconstruction in Female Athletes
NCT07722104Anterior Cruciate Ligament Injuries, Knee Injuries
Universidad Católica San Antonio de Murcia
Observational
82
Alicante
2026-08-01
Recruiting
Janssen Research & Development, LLC
Phase 2
68
Alicante, Madrid
2026-07-28
Recruiting
Carl Zeiss Meditec AG
Phase 4
130
Alicante
2026-07-13
Not yet open
Hospital Universitari Vall d'Hebron Research Institute
Phase 3
15,160
Granada, Barcelona, Girona, Tarragona, Barakaldo, A Coruña, Alicante, Burgos
2026-07-01
Recruiting
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
NCT07106632Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast Cancer
UNICANCER
Phase 3
3,380
Alicante, Barcelona, Castillón, Granada, Madrid, Manresa, Palma, Seville
2026-06-26
Recruiting
ViiV Healthcare
Phase 3
564
Pozuelo de Alarcón, Alicante, Badalona, Barcelona, Burgos, Cartagena Murcia, Córdoba, Elche Alicante
2026-06-25
Recruiting
PETHEMA Foundation
Phase 2
50
Albacete, Alicante, Burgos, Cáceres, Córdoba, Las Palmas, Las Palmas de Gran Canaria, Lugo
2026-06-12
Not yet open
Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia
NCT07384702Bacteremia Due to Staphylococcus Aureus
DrugClopidogrel
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase 2
230
Alicante, Barcelona, Córdoba, Granada, Jerez de la Frontera, Madrid, Palma de Mallorca, Seville
2026-06
Recruiting
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
NCT07599813Atopic Dermatitis, Atopic, Dermatitis, Dermatitis, Atopic
Apollo Therapeutics Ltd
Phase 2
280
Alicante, Badalona, La Paz, Santiago de Compostela, Zaragoza
2026-05-28
Recruiting
UCB Biopharma SRL
Phase 3
120
Alicante, Barcelona, Madrid, Málaga
2026-05-27
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Alicante, Madrid
2026-05-23
Recruiting
Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients
NCT07242547Limited-stage Small-cell Lung Cancer, Carcinoma, Small Cell Lung, Respiratory Tract Neoplasms, Thoracic Neoplasms
DrugTarlatamab
Fundación GECP
Phase 2
37
Albacete, Alicante, Elche, Barcelona, Manresa, Bilbao, Jerez de la Frontera, Lugo
2026-05-20
Not yet open
The Role of Fatigue Associated With Strength Training in Exercise-induced Hypoalgesia
NCT07577622Exercise Induced Hypoalgesia, Healthy Adult Volunteer
Universidad Miguel Hernandez de Elche
Not applicable
27
Alicante
2026-05-15
Not yet open
Prospective International Multi-center Clinical Trial of PGT-A Upgrade
NCT07533630Infertility Assisted Reproductive Technology
Reproductive & Genetic Hospital of CITIC-Xiangya
Observational
1,700
Alicante
2026-05
Recruiting
Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
NCT07611747Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Axial Spondy, Systemic Lupus Erythematosus (SLE)
Instituto de Investigación Marqués de Valdecilla
Phase 4
1,944
Alicante, Elche, Orihuela, Barcelona, Laredo, Santander, Torrelavega, Ciudad Real
2026-04-22
Recruiting
Janssen Research & Development, LLC
Phase 3
530
Alicante, Barcelona, Ferrol, Gijón, Girona, Madrid, Navarra, Santiago de Compostela
2026-04-21
Recruiting
Remibrutinib Open Label Roll-over Post-trial Access Protocol
NCT07456891Indication of the Parent Protocol
DrugRemibrutinib
Novartis Pharmaceuticals
Phase 3
648
Barcelona, Alicante, Córdoba, Madrid, Valencia
2026-04-16
Recruiting
ETOP IBCSG Partners Foundation
Phase 2
48
Alicante, Barcelona, Madrid
2026-04-15
Not yet open
University Hospital, Toulouse
Observational
209
Alicante, Ourense, Pamplona
2026-04-01
Recruiting
Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer
NCT07195227Hormon Receptor Positive Breast Cancer, Breast Cancer
DrugsCamizestrant·Ribociclib
MedSIR
Phase 2
150
Alicante, Barcelona, Girona, Granada, Jerez de la Frontera, León, Madrid, Málaga
2026-03-24
Not yet open
Treatment for Ph-negative ALL for Adults up to 65 Years
NCT07443592Acute Lymphoblastic Leukemia
PETHEMA Foundation
Not applicable
330
A Coruña, Alava, Albacete, Alicante, Almería, Arrecife, Ávila, Badajoz
2026-03-06
Active, closed
University of Alicante
Not applicable
120
Alicante
2026-03-01
Not yet open
Cancer Literacy Education and Awareness Resources for Prostate Care
NCT07437482Health Literacy, Prostate Cancer
Universidad Miguel Hernandez de Elche
Observational
3,100
Alicante
2026-03
Recruiting
Instituto Bernabeu
Observational
164
Alicante
2026-02-26
Recruiting
SOLTI Breast Cancer Research Group
Phase 2
300
Barcelona, A Coruña, Alicante, Badajoz, Bilbao, Girona, Granada, L'Hospitalet de Llobregat
2026-02-18
Recruiting
Boehringer Ingelheim
Phase 3
1,325
A Coruña, Alicante, Barakaldo, Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Salamanca
2026-02-17
Recruiting
ViiV Healthcare
Phase 2
186
A Coruña, Alicante, Almería, Badalona, Barcelona, Elche Alicante, Getafe, Granada
2026-02-11
Recruiting
Instituto Valenciano de Infertilidad, IVI Alicante
Observational
20
Alicante
2026-02-10
Not yet open
Instituto Valenciano de Infertilidad, IVI Alicante
Observational
10
Alicante
2026-02
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
390
A Coruña, Alicante, Barakaldo, Barcelona, Granada, Jerez de la Frontera, Madrid, Santa Cruz de Tenerife
2026-01-12
Not yet open
Movement of Dental Implants During Osseointegration
NCT07297147Dental Implants, Osseointegration
Aula Dental Avanzada
Observational
100
Alicante, Cabezo de Torres, Santa Cruz de Tenerife
2026-01-01
Recruiting
Fundación EPIC
Not applicable
2,100
Alicante, Badalona, Barakaldo, Barcelona, Castelló, Donostia / San Sebastian, El Palmar, Fuencarral-El Pardo
2025-12-19
Recruiting
AstraZeneca
Phase 2
230
Alicante, Badalona, Madrid, Majadahonda, Seville
2025-12-10
Recruiting
Hospital Universitari Vall d'Hebron Research Institute
Not applicable
750
Barcelona, A Coruña, Alicante, Cabueñes, Cadiz, Elche, Getafe, Girona
2025-12-04
Not yet open
Laboratoires Quinton International S.L.
Observational
83
Alicante
2025-12
Recruiting
Syndax Pharmaceuticals
Phase 3
468
Badalona, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Santander, Oviedo, Alicante, Barcelona, Burgos
2025-11-25
By invitation
Celldex Therapeutics
Phase 3
1,370
Alicante, Barcelona, Madrid, Sabadell, Villarreal de Huerva
2025-11-25
Recruiting
PhenoNet, Inc.
Phase 2
105
Alicante, Barcelona, Madrid, Málaga, Seville
2025-11-25
Recruiting
Sanofi
Observational
1,000
Barcelona, Santa Cruz de Tenerife, Alicante
2025-11-17
Recruiting
UCB Biopharma SRL
Phase 3
320
Alicante, Badalona, Granada, Madrid, Manises, Málaga, Santiago de Compostela, Valencia
2025-11-14
Active, closed
Hoffmann-La Roche
Phase 2
193
Las Palmas de Gran Canaria, EL Palmar (EL Palmar), Albacete, Alicante, Barcelona, Madrid, Seville
2025-11-13
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Ribociclib·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Alicante, Barcelona, Granada, León, Lleida, Madrid, Murcia, Seville
2025-11-03
Recruiting
Fundación EPIC
Not applicable
200
Alicante, Barcelona, Córdoba, Fuencarral-El Pardo, Lugo, Madrid, Salamanca, Seville
2025-10-23
Recruiting
A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy
NCT07785180Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc.
Observational
140
Albacete, Alicante, Badalona, Burgos, Cáceres, Córdoba, Madrid, Oviedo
2025-10-17
Not yet open
Instituto Bernabeu
Phase 4
100
Alicante
2025-09-30
Recruiting
Nutritional Knowledge and Characteristics of HYROX Athletes
NCT07531953Assess Dietary Intake, Nutitional Knowledge, Eating Behaviours and Body Composition Characeristics in HIFT Athletes
University of Alicante
Observational
122
Alicante
2025-09-25
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
A Coruña, Alcalá de Henares, Alicante, Antequera, Badajoz, Barcelona, Burjassot, Cadiz
2025-09-22
Recruiting
Zydus Therapeutics Inc.
Phase 2
240
Alicante, Barcelona, Málaga, Valencia
2025-09-17
Recruiting
University of Alicante
Observational
70
Alcoy, Alicante
2025-09-02
By invitation
Outcomes'10
Observational
132
Alicante, Madrid, Oviedo, Palma de Mallorca
2025-08-15
Recruiting
Evaluation of Safety and Effectiveness of an IOL With a Virtual Aperture Optic
NCT05955846Intraocular Lens, Cataract, Presbyopia
Z Optics, Inc.
Not applicable
60
Alicante, Ceuta, Córdoba, Madrid, Palma de Mallorca
2025-08-07
Recruiting
PALACE: Cemiplimab Trial According to ctDNA Levels
NCT06917573Non Small Cell Lung Cancer Metastatic, Lung Diseases, Stage IV Non-small Cell Lung Cancer, Stage III Non-small Cell Lung Cancer
DrugsCarboplatine·Cemiplimab·Paraplatin·Taxol
Fundación GECP
Phase 2
63
Alicante, Elche, Badalona, Barcelona, L'Hospitalet de Llobregat, Bilbao, Jerez de la Frontera, Girona
2025-07-29
Active, closed
Bluefin Biomedicine, Inc.
Phase 2
225
Alicante, Córdoba, Granollers, Madrid
2025-07-15
Recruiting
Pfizer
Phase 3
300
A Coruña, Córdoba, Badalona, Barcelona, Madrid, Vigo, Alicante, Seville
2025-07-14
Recruiting
Fundación GECP
Phase 2
97
Alicante, Badalona, Barcelona, Bilbao, Jerez de la Frontera, Girona, Granada, A Coruña
2025-07-08
By invitation
MoonLake Immunotherapeutics AG
Phase 3
835
Alicante, Badalona, Barcelona, Cadiz, Córdoba, Granada, Granollers, Madrid
2025-06-27
Recruiting
MedSIR
Phase 2
20
Elche, Barcelona, Girona, Madrid, Reus, Alicante, Barakaldo, León
2025-06-27
Active, closed
Incyte Corporation
Phase 3
580
Alicante, Badalona, Barcelona, Madrid
2025-06-23
Recruiting
Intraligamentary vs Inferior Alveolar Nerve Block for Pulpitis: A Randomized Clinical Trial
NCT07130760Symptomatic Irreversible Pulpitis (SIP), Dental Pain, Inferior Alveolar Nerve Block Failure, Local Anesthesia
Aula Dental Avanzada
Not applicable
52
Ferrol, Alicante
2025-06-20
Active, closed
4Moving Biotech
Phase 2
129
A Coruña, Alicante, Sabadell, Santiago de Compostela, Seville
2025-06-17
Active, closed
Incyte Corporation
Phase 3
159
Alicante, Barcelona, Esplugues de Llobregat, Granada, Madrid, Manises, Málaga, Santiago de Compostela
2025-06-17
Recruiting
Orbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified Coronary Nodules (ORBIT-SHOCK).
NCT06736665Coronary Arterial Disease (CAD), Coronary Calcification, Coronary Calcified Nodules, Orbital Atherectomy
Spanish Society of Cardiology
Not applicable
50
Alicante, Lugo, Madrid, Salamanca, Valladolid, Córdoba
2025-06-12
Recruiting
AstraZeneca
Phase 3
15,100
A Coruña, Alicante, Barcelona, Cáceres, Huelva, Madrid, Málaga, Murcia
2025-06-04
Recruiting
Hospital General Universitario de Alicante
Not applicable
82
Alicante
2025-06-01
Not yet open
Does The Addition Of Letrozole To Ultra-Long GnRH Agonists Help Adenomyosis Patients in ART? The AURA Trial
NCT06985186Adenomyosis of Uterus, Infertility Assisted Reproductive Technology
DrugLetrozole
University of Palermo
Phase 4
162
Alicante
2025-06
Recruiting
W.L.Gore & Associates
Observational
158
Alicante
2025-05-30
Recruiting
Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria
NCT06865651Chronic Urticaria (CU): Chronic Inducible Urticaria (CINDU) and Chronic Spontaneous Urticaria (CSU)
DrugRemibrutinib
Novartis Pharmaceuticals
Phase 2
44
Barcelona, Pamplona, Alicante, Madrid
2025-05-22
Recruiting
Novartis Pharmaceuticals
Phase 2
224
Badalona, Alicante, Granada, Las Palmas GC, Madrid, Pontevedra
2025-05-16
Recruiting
Instituto de Investigación Sanitaria y Biomédica de Alicante
Observational
376
Alicante
2025-05-15
Recruiting
Fundación EPIC
Observational
500
Albacete, Alicante, Badajoz, Castelló, Ciudad Real, Elche, L'Hospitalet de Llobregat, Laguna
2025-05-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Alicante, Barcelona, Girona, Lleida, Madrid, Palma de Mallorca, Tarragona, Valencia
2025-05-05
Recruiting
Optimising TREATment for Severe Gram-Negative Bacterial Infections
NCT07004049Bloodstream Infection, Ventilator Associated Bacterial Pneumonia, Hospital Acquired Bacterial Pneumonia, Carbapenem Resistant Bacterial Infection
DrugsCeftolozane-tazobactam·Cefiderocol·Fosfomycin·Meropenem-Vaborbactam
National University of Singapore
Phase 4
600
Alicante, Badajoz, Barakaldo, Barcelona, Córdoba, Granada, Madrid, Málaga
2025-04-21
Active, closed
Janssen Research & Development, LLC
Phase 3
752
Alicante, Barakaldo, Barcelona, Granada, Madrid, Manises, Santiago Compostela, Seville
2025-04-15
Recruiting
Inmunotek S.L.
Phase 3
736
Benidorm, Alicante
2025-04-02
Recruiting
The Pivotal Study of RapidPulseTM Aspiration System
NCT06029491Acute Ischemic Stroke
RapidPulse, Inc
Not applicable
170
Alicante, Badalona, Barcelona, Girona, Madrid
2025-03-27
Recruiting
AbbVie
Phase 1/2
252
Santander, Seville, A Coruña, Alicante, Barcelona, Málaga
2025-03-06
Recruiting
Instituto de Investigación Marqués de Valdecilla
Observational
330
Santander, Alicante, Barcelona, Bilbao, Burgos, Madrid, Oviedo, Toledo
2025-03-01
Recruiting
Incyte Corporation
Phase 3
600
Alcorcón, Alicante, Badalona, Barcelona, Córdoba, Granada, Las Palmas de Gran Canaria, Madrid
2025-02-28
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 3
339
Albacete, Alicante, Barcelona, Valencia
2025-02-27
Active, closed
Procare Health Iberia S.L.
Observational
300
Sitges, Getafe, Benalmádena, Estella-Lizarra, A Coruña, Alicante, Almería, Barcelona
2025-02-13
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,000
Albacete, Alicante, Barakaldo, Burgos, Cadiz, Cantabria, Córdoba, Donostia / San Sebastian
2025-02-12
Recruiting
Dianthus Therapeutics
Phase 3
256
Barcelona, Alicante, Bilbao
2025-02-10
Recruiting
Fundación GECP
Phase 3
129
Alicante, Elche, Badalona, Barcelona, L'Hospitalet de Llobregat, Bilbao, Jerez de la Frontera, A Coruña
2025-02-04
Recruiting
Airway Therapeutics, Inc.
Phase 2/3
366
Alicante, Barcelona, Bilbao, Cadiz, Lleida, Madrid, Málaga, Santiago de Compostela
2025-02-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Seville, L'Hospitalet de Llobregat, Barakaldo, Las Palmas de Gran Canaria, Majadahonda, Gijón, Alicante, Barcelona
2025-01-27
Recruiting
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Not applicable
1,255
Alicante
2025-01-23
Active, closed
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
NCT06846541Plaque Psoriasis, Psoriasis (PsO), Psoriasis, Moderate Psoriasis
Alumis Inc
Phase 3
1,680
Alicante, Barcelona, Madrid, A Coruña, Manises
2025-01-08
Active, closed
AstraZeneca
Phase 3
101
Alicante, Barcelona, Bilbao (Vizcaya), Córdoba, Donostia / San Sebastian, El Palmar, Girona, Madrid
2025-01-07
Recruiting
Aula Dental Avanzada
Not applicable
40
Alicante, Cabezo de Torres
2025-01-01
Active, closed
AstraZeneca
Phase 3
45
A Coruña, Alicante, Barakaldo, Barcelona, Córdoba, El Palmar, Girona, L'Hospitalet de Llobregat
2024-12-30
Recruiting
UNICANCER
Phase 2
354
Alicante, Badalona, Barcelona, El Palmar, Granada, L'Hospitalet de Llobregat, León, Lleida
2024-12-27
Recruiting
Fundación para la Investigación Biosanitaria del Principado de Asturias
Not applicable
250
Alicante, Barcelona, L'Hospitalet de Llobregat, Santander, Córdoba, Las Palmas de Gran Canaria, Madrid, Málaga
2024-12-24
Active, closed
argenx
Phase 3
154
Alicante, Badalona, Barcelona, Madrid, Málaga, San Sebastián
2024-12-18
By invitation
PrEveNtion of Biliary Events After Acute Pancreatitis in NonSUrgicaL PAtients: PENINSULA Trial
NCT06409741Acute Pancreatitis Due to Gallstones, Acute Pancreatitis
Hospital General Universitario de Alicante
Not applicable
126
Alicante, Córdoba, Madrid, Valencia, Valladolid
2024-12-16
Recruiting
Spanish Oncology Genito-Urinary Group
Observational
500
Albacete, Alicante, Almería, Córdoba, Granada, Jaén, Jerez de la Frontera, Málaga
2024-12-13
Recruiting
Pfizer
Phase 3
2,330
A Coruña, Benalmádena, Córdoba, Badalona, Barcelona, Madrid, Vigo, Alicante
2024-12-08
Recruiting
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
NCT06382948Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, ESR1 Gene Mutation
DrugsElacestrant·Everolimus
MedSIR
Phase 3
300
Barcelona, A Coruña, Alicante, Badalona, Bilbao, Burgos, Castellon, Cáceres
2024-12-05
Recruiting
iPremom
Observational
7,473
Alicante, Barcelona, Vinaròs, Cadiz, A Coruña, Torrejón de Ardoz, El Palmar, San Cristóbal de La Laguna
2024-12-02
Active, closed
Genmab
Phase 3
191
L'Hospitalet de Llobregat, Córdoba, Santiago de Compostela, Las Palmas de Gran Canaria, Pozuelo de Alarcón, Marbella, Pamplona, Alicante
2024-11-25
Recruiting
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
NCT06369285Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer
DrugAlisertib
Puma Biotechnology, Inc.
Phase 2
225
Alicante, Barakaldo, Barcelona, Bilbao, Cáceres, Granada, Huelva, Jaén
2024-11-19
Active, closed
Daiichi Sankyo
Phase 3
700
Albacete, Alicante, Badalona, Barcelona, Burgos, Cáceres, Córdoba, Las Palmas
2024-11-19
Active, closed
Sanofi
Observational
143
Santiago de Compostela, Esplugues de Llobregat, Oviedo, Seville, Alicante, Barcelona, Madrid, Málaga
2024-11-14
Recruiting
Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease
NCT06788275Percutaneous Coronary Intervention (PCI), Acute Myocardial Infarction, Angina (Stable), Unstable Angina Pectoris
Instituto de Investigación Sanitaria y Biomédica de Alicante
Not applicable
132
Alicante, Elche
2024-11-01
Recruiting
North Eastern German Society of Gynaecological Oncology
Phase 2
640
Alicante, Granada, Lugo, Madrid, Manresa, Seville, Tarragona, Valencia
2024-10-11
Active, closed
Incyte Corporation
Phase 3
346
Alicante, Badalona, Barcelona, Córdoba, Granada, Madrid, Majadahonda, Manises
2024-10-10
Recruiting
Fundación GECP
Observational
50
Ferrol, Alicante, Badalona, Barcelona, Bilbao, Ciudad Real, Girona, A Coruña
2024-10-03
Recruiting
Instituto de Investigación Sanitaria y Biomédica de Alicante
Phase 3
42
Alicante, Elche
2024-10-01
Active, closed
Dianthus Therapeutics
Phase 2
46
Alicante, Barcelona
2024-09-17
Active, closed
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
NCT06430866Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
DrugsABP 234·Pembrolizumab
Amgen
Phase 3
163
A Coruna Galicia, A Coruña, Alicante, Badalona, Barcelona, Jerez de la Frontera, Madrid, Mataró
2024-09-12
Recruiting
Fundación Sociedad Española de Oncologia Médica
Observational
540
Santander, Ciudad Real, Cuenca, Alicante, Arganda, Fuencarral-El Pardo, Fuenlabrada, Salamanca
2024-09-12
Active, closed
Amgen
Phase 3
315
Alicante, Barcelona, Jaén, Madrid, Mataró, Málaga, Oviedo, Seville
2024-09-09
Recruiting
PETHEMA Foundation
Phase 2
106
Alicante, Barcelona, Córdoba, Las Palmas de Gran Canaria, Madrid, Marbella, Málaga, Oviedo
2024-09-02
Active, closed
Novartis Pharmaceuticals
Phase 3
146
Santiago Compostela, L'Hospitalet de Llobregat, Alicante, Barcelona, Lleida, Madrid, Málaga, Valencia
2024-07-31
Active, closed
MedSIR
Phase 2
165
Seville, Alicante, Barcelona, Bilbao, Castellon, Córdoba, Granada, León
2024-07-22
Recruiting
Vor Biopharma
Phase 3
180
Alicante, Barcelona, Terrassa, Bilbao, Valencia
2024-07-17
Recruiting
Juan M Garcia-Gomez
Observational
140
Alicante, Barcelona, Murcia, Santa Cruz de Tenerife, Valencia
2024-07-16
Active, closed
Cardiovascular and Interventional Radiological Society of Europe
Observational
400
Alicante, Granollers, Pamplona
2024-07-15
Active, closed
Celldex Therapeutics
Phase 3
963
Sabadell, Alicante, Barcelona, Córdoba, Madrid, Salamanca, Villarreal de Huerva
2024-07-11
Active, closed
Almirall, S.A.
Phase 3
520
Alicante, Barcelona, Granada, Valencia
2024-07-03
Active, closed
UCB Biopharma SRL
Phase 3
176
Alicante, Esplugues de Llobregat, Granada
2024-06-25
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Badalona, Málaga, El Palmar, A Coruña, Alicante, Barcelona, Lleida, Madrid
2024-06-25
Recruiting
LEO Pharma
Phase 3
195
Alicante, Madrid, Valencia
2024-06-10
Active, closed
MedSIR
Phase 2
28
Alicante, Barcelona, Bilbao, Córdoba, Granada, Madrid, Seville, Valencia
2024-06-05
Not yet open
Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler
NCT05284474Fetal Growth Retardation, Preeclampsia, Placenta Diseases
Hospital Universitari Vall d'Hebron Research Institute
Not applicable
340
A Coruña, Alicante, Badalona, Barcelona, Cadiz, Elche, Getafe, Gijón
2024-06-03
Recruiting
Fundación EPIC
Not applicable
150
Alicante, Badajoz, Huelva, Seville
2024-05-31
Recruiting
PENTA Foundation
Not applicable
3,080
Alicante, Bilbao, Málaga
2024-05-28
Recruiting
Société des Produits Nestlé (SPN)
Not applicable
380
Alicante, Barcelona, Madrid, Salamanca, Sant Cugat del Vallès, Seville, Valencia
2024-05-24
Active, closed
Sanofi
Phase 3
1,541
Esplugues de Llobregat, Bilbao, Las Palmas de Gran Canaria, Pamplona, Vigo, Seville, Burjassot - Valencia, Alicante
2024-05-08
Recruiting
Aula Dental Avanzada
Observational
600
Alicante
2024-05-07
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Alicante, Barcelona, Bilbao, El Palmar, Galdakao, Granada, L'Hospitalet de Llobregat, Madrid
2024-05-06
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
482
Alicante, Barcelona, Madrid
2024-05-01
Active, closed
A Study Evaluating APG777 in Atopic Dermatitis
NCT06395948Atopic Dermatitis
DrugAPG777
Apogee Therapeutics, Inc.
Phase 2
470
Santiago de Compostela, Badalona, Las Palmas de Gran Canaria, Alicante, Barcelona, Madrid, Zaragoza
2024-04-29
Active, closed
Janssen-Cilag Ltd.
Phase 3
120
Alicante, Córdoba, Ferrol, Madrid, Valencia, Vigo
2024-04-17
Active, closed
argenx
Phase 3
119
Alicante, Barcelona, Lleida, Madrid, Santiago de Compostela, Valencia
2024-04-16
Active, closed
Celldex Therapeutics
Phase 2
140
A Coruña, Alicante, Barcelona, Madrid, Seville
2024-04-12
Recruiting
AstraZeneca
Phase 3
675
Alicante, Barcelona, Jerez de la Frontera, Reus, Salamanca
2024-04-11
Recruiting
Integrated Approach in Frail Older People with Atrial Fibrillation
NCT06775028Atrial Fibrillation (AF), Hypertension, Coronary Arterial Disease (CAD), Heart Failure
Heart Care Foundation
Not applicable
1,250
Alicante, Cartagena, Cártama, Elche, Málaga, Murcia, Sant Joan d'Alacant, Tarragona
2024-04-11
Active, closed
Fundación EPIC
Observational
153
Alicante, Aravaca, Barcelona, Cadiz, Córdoba, El Palmar, Gijón, Huelva
2024-04-04
Active, closed
MedSIR
Phase 2
976
A Coruña, Alicante, Barcelona, Bilbao, Castellon, Córdoba, Elche, Girona
2024-04-01
Recruiting
Italfarmaco
Phase 3
220
Badalona, Alicante, Madrid, Málaga, Valencia
2024-03-26
Recruiting
Fundación para la Investigación del Hospital Clínico de Valencia
Observational
70
Alicante, Badajoz, Barcelona, Candelaria, Castellon, Málaga, Murcia, Palma de Mallorca
2024-03-21
Active, closed
Sanofi
Phase 3
464
Badalona, Majadahonda, Seville, Alicante, Madrid
2024-02-29
Active, closed
Fundación EPIC
Observational
501
Albacete, Alicante, Barakaldo, Boadilla del Monte, Ciudad Real, Granada, Huelva, L'Hospitalet de Llobregat
2024-02-26
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
762
Palma, A Coruña, Barcelona, Alicante, Badalona, Castellon, Madrid, Málaga
2024-02-21
Recruiting
AstraZeneca
Phase 3
5,250
Alicante, Badia Del Vallès, Barakaldo, Barcelona, Castro Urdiales, Córdoba, Granada, Madrid
2024-02-21
Active, closed
Janssen Research & Development, LLC
Phase 2
305
A Coruña, Alicante, Barcelona, Jaén, Lugo, Madrid, Málaga, Seville
2024-02-16
Active, closed
Boehringer Ingelheim
Phase 3
428
A Coruña, Alicante, Barcelona, Bilbao, Madrid, Málaga, Seville, Valencia
2024-02-09
Active, closed
Incyte Corporation
Phase 3
617
Alicante, Badalona, Barcelona, Granada, Las Palmas de Gran Canaria, Madrid, Manises, Pontevedra
2024-01-30
By invitation
AST Products, Inc.
Observational
150
Alicante
2024-01-17
Active, closed
Janssen Research & Development, LLC
Phase 3
774
Alicante, Barakaldo, Barcelona, Granada, L'Hospitalet de Llobregat, Madrid, Valencia
2024-01-17
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
NCT06064877Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsErbitux·Cetuximab
AVEO Pharmaceuticals, Inc.
Phase 3
410
Alicante, Badalona, Barcelona, Cadiz, Madrid, Málaga, Santander, Valencia
2024-01-11
Recruiting
Regeneron Pharmaceuticals
Phase 1/2
149
Badalona, Pozuelo de Alarcón, Pamplona, Oviedo, Alicante, Barcelona, Madrid, Salamanca
2023-12-19
Recruiting
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
NCT05512364ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer
DrugsElacestrant·Tamoxifen·Exemestane·Anastrozole
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
220
Alicante, Barakaldo, El Palmar, Girona, Granada, L'Hospitalet de Llobregat, Lleida, Madrid
2023-12-15
Active, closed
Novartis Pharmaceuticals
Phase 3
362
Santiago, Granada, Barcelona, Alicante, Madrid, Valencia
2023-12-07
Active, closed
AnaptysBio, Inc.
Phase 2
132
Alicante, Lleida
2023-12-04
Recruiting
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism
Hamilton Health Sciences Corporation
Not applicable
4,000
Vigo, Alicante, Barcelona, Huelva, León, Madrid, Valladolid
2023-11-30
Active, closed
argenx
Observational
413
Alicante, Badalona, Barcelona, Bilbao, L'Hospitalet de Llobregat, Oviedo, Pamplona, San Sebastián
2023-11-29
Recruiting
Carlos Simon Foundation
Observational
2,084
Alicante, Murcia, Santa Cruz de Tenerife, Valencia
2023-11-20
Recruiting
Charite University, Berlin, Germany
Not applicable
3,595
Alicante, Madrid, Murcia
2023-11-16
Active, closed
Nektar Therapeutics
Phase 2
396
Alicante, Córdoba, Granada, Seville, Zaragoza
2023-11-15
Active, closed
AstraZeneca
Phase 3
895
Alicante, Barcelona, Bilbao (Vizcaya), Madrid, Málaga, Palma
2023-10-24
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Unresectable Breast Cancer, Metastatic Breast Cancer, HER2-low Expressing Breast Cancer, HER2-(Ultra)Low Expressing Breast Cancer
DrugTrastuzumab deruxtecan
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
2,295
Albacete, Alicante, Alzira, Barakaldo, Barcelona, Bilbao, Cadiz, Cáceres
2023-10-24
Active, closed
Janssen Research & Development, LLC
Phase 3
684
Alcorcón, Alicante, Barcelona, Bilbao, Madrid, Palma de Mallorca, Santiago de Compostela, Seville
2023-10-12
Active, closed
AstraZeneca
Phase 3
5,511
A Coruña, Albacete, Alicante, Badalona, Barakaldo, Barcelona, Burgos, Castellon
2023-10-05
Recruiting
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Not applicable
900
Santiago de Compostela, L'Hospitalet de Llobregat, Sabadell, A Coruña, Majadahonda, Oviedo, Alicante, Barcelona
2023-09-06
Recruiting
OSIREAL - Osimertinib RWE on EGFRm NSCLC in Spain
NCT06068049Non-small Cell Lung Cancer
AstraZeneca
Observational
500
A Coruña, Alicante, Barcelona, C Rdoba, El Palmar, Girona, Granada, Jaén
2023-07-28
Active, closed
Alumis Inc
Phase 2
408
A Coruña, Alicante, Barcelona, Seville, Valencia
2023-06-26
Recruiting
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
NCT05427370Coronary Artery Disease, Heart Failure Systolic
Sunnybrook Health Sciences Centre
Not applicable
754
Barcelona, El Palmar, Alicante, Pamplona
2023-06-22
Active, closed
ETOP IBCSG Partners Foundation
Phase 2
68
A Coruña, Alicante, Badalona, Bilbao, L'Hospitalet de Llobregat, Madrid, Valencia
2023-06-12
Active, closed
Janssen Research & Development, LLC
Phase 1/2
71
Alicante, Barcelona, Madrid, Seville, Valencia
2023-05-18
Active, closed
Fundación GECP
Phase 2
22
Alicante, Barcelona, Mataró, Bilbao, Cáceres, Jerez de la Frontera, Girona, Jaén
2023-05-12
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
A Coruña, Alicante, Barcelona, El Palmar, Lleida, Madrid, Manises, Málaga
2023-04-11
Active, closed
Alfasigma S.p.A.
Phase 3
495
Alicante, Barcelona, Bilbao, Córdoba, Madrid, Santander, Santiago de Compostela, Seville
2023-04-05
Active, closed
Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation
NCT05758909Aortic Valve Disease, Aortic Valve Stenosis, Heart Valve Diseases
Fundación EPIC
Observational
585
A Coruña, Alicante, Aravaca, Badalona, Barcelona, L'Hospitalet de Llobregat, Málaga, Oviedo
2023-04-04
Active, closed
Sanofi
Phase 2
999
Badalona, Sabadell, Alicante, Córdoba, Madrid, Valencia
2023-04-03
Recruiting
AstraZeneca
Phase 3
4,300
A Coruña, Albacete, Alcoy, Alicante, Alzira, Badajoz, Badalona, Barakaldo
2023-03-31
Active, closed
Sequent Extended Study
NCT05788432Coronary Artery Disease, Ischemic Heart Disease
Fundación EPIC
Observational
2,040
Alava, Alicante, Badajoz, Badalona, Barakaldo, Barcelona, Cadiz, Castelló
2023-03-28
Active, closed
ETOP IBCSG Partners Foundation
Phase 2
60
A Coruña, Alicante, Badalona, Barcelona, Bilbao, L'Hospitalet de Llobregat, Madrid, Valladolid
2023-03-27
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
A Coruña, Albacete, Alicante, Badalona, Barakaldo, Barcelona, Córdoba, Girona
2023-02-15
Active, closed
Fundación EPIC
Not applicable
609
L'Hospitalet de Llobregat, A Coruña, Albacete, Alicante, Badalona, Barcelona, Cadiz, Castellon
2023-01-30
Recruiting
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
NCT05658575Acute Gout Flare, Gout Attack, Gout Flare, Gouty Arthritis
DrugDapansutrile
Olatec Therapeutics, Inc.
Phase 2/3
300
Alicante, Barcelona, Madrid
2023-01-06
Recruiting
Greenwich LifeSciences, Inc.
Phase 3
2,250
Albacete, Alicante, Badajoz, Barcelona, Cáceres, Córdoba, El Palmar, Fuenlabrada
2022-12-16
Active, closed
Janssen Research & Development, LLC
Phase 1/2
57
A Coruña, Alicante, Barcelona, Madrid, Seville, Valencia
2022-12-13
Active, closed
Novartis Pharmaceuticals
Phase 3
696
Barcelona, Alicante, Las Palmas GC, Madrid, Valencia
2022-12-09
Recruiting
Janssen Research & Development, LLC
Phase 2
520
A Coruña, Alicante, Barcelona, Madrid, Málaga, Seville, Valencia
2022-11-11
Active, closed
Fundación GECP
Phase 2
46
Alicante, Badalona, Barcelona, Bilbao, Girona, A Coruña, Lugo, Madrid
2022-11-07
Recruiting
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
L'Hospitalet de Llobregat, Barcelona, San Cristóbal de La Laguna, Alicante, Córdoba, Lleida, Madrid, Málaga
2022-10-24
Recruiting
Stalicla SA
Observational
1,500
Alicante, Barcelona, Madrid, Majadahonda, San Sebastián, Vigo
2022-10-13
Active, closed
Utility of CYP2D6 Genotyping to Improve the Efficacy and Safety of Tramadol
NCT05657704Post-surgical Pain, Pain, Acute, Postoperative Pain
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Phase 4
300
Majadahonda, Alicante, Burgos, Madrid
2022-10-05
Active, closed
Eli Lilly and Company
Phase 3
8,000
A Coruña, Alicante, Almería, Badajoz, Barcelona, Bilbao, Burgos, Cáceres
2022-10-04
Recruiting
Fundación para la Investigación del Hospital Clínico de Valencia
Phase 3
78
Alicante, Barcelona, Madrid, Valencia
2022-09-30
Recruiting
Janssen Research & Development, LLC
Phase 2/3
201
Alicante, Barcelona, Bilbao, Donostia / San Sebastian, Madrid, Seville
2022-09-23
Active, closed
VisionCare, Inc.
Not applicable
68
Alicante, Barcelona, Madrid
2022-09-13
Recruiting
Fundacion Clinic per a la Recerca Biomédica
Phase 4
360
Alicante, Seville, Palma de Mallorca, Barcelona, Sabadell, Terrassa, Barakaldo, Santander
2022-08-17
Active, closed
Janssen Research & Development, LLC
Phase 3
418
A Coruña, Alicante, Barcelona, Córdoba, Las Palmas de Gran Canaria, Lugo, Madrid, Majadahonda
2022-08-05
Recruiting
Aula Dental Avanzada
Observational
150
Alicante
2022-07-29
Active, closed
The Left Bundle Cardiac Resynchronization Therapy Trial
NCT05434962Left Bundle-Branch Block, Heart Failure, Impaired Left Ventricular Function
Óscar Cano Pérez
Not applicable
176
Alicante, L'Hospitalet de Llobregat, Granada, Huelva, Madrid, Majadahonda, Murcia, Valencia
2022-06-27
Active, closed
Fundación GECP
Observational
100
A Coruña, Alicante, Badalona, Barcelona, Bilbao, Córdoba, Girona, Pamplona
2022-06-17
Recruiting
AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
NCT05211570Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Myelodysplastic Syndrome Acute Myeloid Leukemia
DrugVenetoclax
AB Science
Phase 1/2
78
Alicante, Cáceres, Madrid, Pamplona, Seville
2022-06-01
Active, closed
Sanofi
Phase 3
104
Madrid, Alicante, Pontevedra
2022-05-03
Recruiting
AstraZeneca
Phase 2
630
A Coruña, Alicante, Barcelona, Córdoba, Madrid, Majadahonda, Málaga, Reus
2022-04-14
Recruiting
Fundación GECP
Phase 2
19
Alicante, Badalona, Barcelona, Bilbao, Girona, Granada, Jaén, A Coruña
2022-03-21
Recruiting
Sanofi
Phase 3
284
Barcelona, Pontevedra, Alicante, Córdoba
2022-02-15
Active, closed
NewAmsterdam Pharma
Phase 3
9,541
A Coruña, Alicante, Almería, Barcelona, Córdoba, Granada, Madrid, Málaga
2022-02-07
Active, closed
A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
NCT05002127Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Gastric Adenocarcinoma
DrugsEvorpacept·Ramucirumab·Herceptin·Taxol
ALX Oncology Inc.
Phase 2/3
127
Alicante, Badalona, Barcelona, Córdoba, Lugo, Madrid, Santander, Zaragoza
2022-01-15
Recruiting
National GMA Post-market Clinical Follow-up Study (GRACE)
NCT05636709Crohn Disease, Ulcerative Colitis
Adacyte Therapeutics SL
Observational
350
Albacete, Alicante, Badalona, Barcelona, Galdakao, Castellon, Cadiz, Córdoba
2022-01-11
Recruiting
Pathological Response After Neoadjuvant Treatment on NSCLC
NCT05167487Stage IIIA Non-small Cell Lung Cancer
DrugsParaplatin·Cisplatin·Carboplatin
Fundación GECP
Observational
150
A Coruña, Alicante, Badalona, Barcelona, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Majadahonda
2021-12-13
Recruiting
Hospital General Universitario de Alicante
Phase 3
332
Santiago de Compostela, Alicante, Elche, Barcelona, L'Hospitalet de Llobregat, Sabadell, Santander, Granada
2021-11-10
Active, closed
Spanish Breast Cancer Research Group
Phase 3
27
A Coruña, Albacete, Alicante, Badajoz, Badalona, Barcelona, Bilbao, Cadiz
2021-09-14
Active, closed
AstraZeneca
Phase 3
98
Alicante, Barcelona, Córdoba, León, Madrid, Málaga, Murcia, Oviedo
2021-09-12
Active, closed
MedSIR
Phase 2
393
L'Hospitalet de Llobregat, Córdoba, Reus, A Coruña, Alicante, Badalona, Barcelona, Bilbao
2021-08-05
Recruiting
Janssen Research & Development, LLC
Phase 3
199
Alicante, Barcelona, Bilbao, Seville, Valencia
2021-07-15
Active, closed
Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation
NCT04788888Symptomatic Severe Aortic Stenosis
Abbott Medical Devices
Not applicable
434
Madrid, Alicante, Barcelona, Seville
2021-07-13
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 3
434
Alicante, Badajoz, Badalona, Barcelona, Cadiz, Jaén, Madrid, Málaga
2021-07-06
Active, closed
Fertypharm
Not applicable
84
Alicante, Zaragoza
2021-05-05
Active, closed
AstraZeneca
Phase 3
1,157
Alicante, Barcelona, Madrid, Majadahonda, Seville
2021-04-26
Active, closed
ANGiographic Evaluation of Left Main Coronary Artery INtErvention
NCT04604197Coronary Occlusion, Left Main Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease
Fundación EPIC
Not applicable
400
Badalona, Barakaldo, Donostia / San Sebastian, Málaga, Galdakao, A Coruña, Albacete, Alicante
2021-04-16
Active, closed
Incyte Corporation
Phase 3
654
A Coruña, Alicante, Badalona, Barcelona, Burgos, Gijón, L'Hospitalet de Llobregat, Madrid
2021-04-15
Active, closed
Geron Corporation
Phase 3
327
Alicante, Badalona, Las Palmas de Gran Canaria, Cáceres, Granada, Madrid, Málaga, Zaragoza
2021-04-12
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
L'Hospitalet de Llobregat, Salamanca, A Coruña, Alicante, Barcelona, Madrid
2021-04-05
Recruiting
Bristol-Myers Squibb
Phase 3
153
Alicante, Barakaldo, Esplugues de Llobregat, Las Palmas de GC, Madrid
2021-03-23
Active, closed
SOLTI Breast Cancer Research Group
Phase 2
55
Granada, Barcelona, L'Hospitalet de Llobregat, Santa Cruz de Tenerife, A Coruña, Alicante, Cáceres, León
2021-03-15
Active, closed
Soft Tissue Volume Changes After Immediate Implants With Two Different Techniques
NCT04803110Dental Implant, Tooth Extraction, Bone Resorption
Aula Dental Avanzada
Not applicable
20
Alicante
2021-03-01
Active, closed
Mirati Therapeutics Inc.
Phase 3
453
Pamplona, A Coruña, Alicante, Badalona, Barakaldo, Barcelona, Córdoba, Girona
2021-02-23
Recruiting
AB Science
Phase 3
495
Alicante, Barcelona, Madrid, Santiago de Compostela, Valencia
2021-02-02
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
5,000
Albacete, Alcorcón, Alcoy, Alicante, Almería, Asturias, Badajoz, Barakaldo
2021-01-15
Active, closed
New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy
NCT04564157Non-Small Cell Lung Cancer, Adjuvant Chemotherapy
DrugsParaplatin·Taxol·Opdivo·Nivolumab
Fundación GECP
Phase 3
210
Alicante, Badalona, Barcelona, L'Hospitalet de Llobregat, Bilbao, Cáceres, El Palmar, Girona
2021-01-13
Recruiting
Natural History of Clostridioides Difficile Infection
NCT04801862Clostridium Difficile Infection, Health Care Associated Infection, Nosocomial Infection
Hospital Universitario de Valme
Observational
750
Alicante, Orihuela, Villajoyosa, Puerto Real, Granada, Huelva, Málaga, Valencia
2021-01-01
Active, closed
Daiichi Sankyo
Phase 3
1,600
Bilbao, El Palmar, Reus, A Coruña, Alcorcón, Alicante, Badajoz, Barcelona
2020-12-04
Active, closed
Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy
NCT04463641Heart Failure, Cardiac Resynchronization Therapy
MicroPort CRM
Not applicable
92
Alicante, Valencia, Vigo
2020-12-03
Active, closed
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
NCT04595565HER2-negative Breast Cancer, Triple Negative Breast Cancer
DrugsXeloda·Sacituzumab Govitecan·Paraplatin·Capecitabine
GBG Forschungs GmbH
Phase 3
1,332
Barakaldo, A Coruña, Albacete, Alcorcón, Alcoy, Alicante, Badalona, Barcelona
2020-10-28
Recruiting
Abbott Vascular Medical Device Registry
NCT04573660Acute Myocardial Infarction, Restenoses, Coronary, Coronary Artery Lesions, Venous Embolism
Abbott Medical Devices
Observational
3,784
Barcelona, Madrid, Alicante
2020-10-25
Active, closed
Spanish Breast Cancer Research Group
Phase 2
200
Santiago de Compostela, L'Hospitalet de Llobregat, Santander, Castellon, San Sebastián, Vigo, A Coruña, Alicante
2020-10-02
Active, closed
AbbVie
Phase 3
527
Ferrol, Santiago de Compostela, Badalona, L'Hospitalet de Llobregat, Fuenlabrada, Majadahonda, Oviedo, Alicante
2020-09-30
Active, closed
Incyte Corporation
Phase 2
112
Alicante, Badalona, Barcelona, Boadilla del Monte, L'Hospitalet de Llobregat, Madrid, Pozuelo de Alarcón, Salamanca
2020-08-03
Active, closed
Clinical Utility of Liquid Biopsy in Brigatinib ALK+ Patients
NCT04223596Lung Cancer, NSCLC, NSCLC Stage IIIB, NSCLC Stage IV
DrugBrigatinib
Fundación GECP
Phase 2
33
A Coruña, Alicante, Málaga, Palma de Mallorca, Badalona, L'Hospitalet de Llobregat, Barcelona, Las Palmas de Gran Canaria
2020-05-04
Recruiting
Spanish Registry of Esophagogastric Cancer
NCT04958720Esophageal Cancer, Gastric Cancer
Fundación Sociedad Española de Oncologia Médica
Observational
10,000
Alicante, Elche, Elda, Córdoba, Málaga, Seville, Palma de Mallorca, Barcelona
2020-04-27
Active, closed
Eli Lilly and Company
Phase 3
261
Palma de Mallorca, Badalona, Santiago de Compostela, Las Palmas de Gran Canaria, Majadahonda, Pamplona, Alicante, Barcelona
2020-02-17
Active, closed
Takeda
Phase 3
354
L'Hospitalet de Llobregat, A Coruña, Alicante, Barcelona, Córdoba, Madrid, Valencia
2020-01-10
Active, closed
Galderma R&D
Phase 3
1,700
Alicante, Barcelona, L'Hospitalet de Llobregat, Las Palmas de Gran Canaria, Madrid, Pamplona
2019-12-30
Recruiting
PETHEMA Foundation
Not applicable
300
Badalona, A Coruña, Albacete, Alicante, Ávila, Barcelona, Bellvitge, Bilbao
2019-11-25
Active, closed
NeuroDerm Ltd.
Phase 3
381
Oviedo, Alicante, Barcelona, Burgos, Madrid, Seville, Valencia
2019-09-30
Active, closed
Pfizer
Phase 3
896
Alicante, Madrid
2019-09-05
Recruiting
Mats Heyman
Observational
500
Alicante, Barakaldo, Barcelona, Fuencarral-El Pardo, Madrid, Murcia, Palma de Mallorca, Santander
2019-08-29
Active, closed
ETOP IBCSG Partners Foundation
Phase 3
405
San Cristóbal de La Laguna, A Coruña, Alicante, Barcelona, Bilbao, Girona, Madrid, Málaga
2019-08-27
Recruiting
University Hospital Muenster
Phase 3
683
Alicante, Almería, Badajoz, Barakaldo, Barcelona, Donostia / San Sebastian, Esplugues de Llobregat, Granada
2019-08-23
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Donostia / San Sebastian, Majadahonda, Pamplona, A Coruña, Alicante, Badalona, Barcelona, Burgos
2019-08-09
Active, closed
Infant Bacterial Therapeutics
Phase 3
2,158
Alicante, Madrid, Tarragona, Valencia
2019-07-04
Active, closed
NADIM II: Neo-Adjuvant Immunotherapy
NCT03838159Non Small Cell Lung Cancer
DrugsParaplatin·Taxol·Opdivo·Nivolumab
Fundación GECP
Phase 2
90
Alicante, Badalona, Barcelona, L'Hospitalet de Llobregat, Córdoba, Girona, Las Palmas de Gran Canaria, A Coruña
2019-05-15
Active, closed
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
NCT03253263Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Intraventricular Hemorrhage, Retinopathy of Prematurity (ROP)
OHB Neonatology Ltd.
Phase 2
295
Alicante
2019-05-09
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Alicante, Badalona, Barcelona, Córdoba, L'Hospitalet de Llobregat, Madrid, Santander, Seville
2019-03-21
Recruiting
Fundación Academia Española de Dermatología
Observational
2,500
Badalona, Alicante, Barcelona, Las Palmas, Madrid, Pontevedra, Valencia, Zaragoza
2019-01-01
Active, closed
AstraZeneca
Phase 3
825
Alicante, Barcelona, Donostia / San Sebastian, Madrid, Málaga, Oviedo, Pamplona, Santiago de Compostela (A Coruña)
2018-12-06
Active, closed
PETHEMA Foundation
Phase 3
462
A Coruña, Albacete, Alicante, Badalona, Barcelona, Bilbao, Cáceres, Córdoba
2018-10-22
Active, closed
Fondazione Michelangelo
Phase 3
650
A Coruña, Alcoy, Alicante, Badajoz, Barcelona, Bilbao, Cáceres, Granada
2018-09-07
Active, closed
AbbVie
Phase 3
1,533
Puerto Real, Alicante, Barcelona, Madrid
2018-08-09
Active, closed
Eli Lilly and Company
Phase 3
1,058
Alicante, Fuenlabrada, Girona, Huelva, Las Palmas de GC, Madrid, Oviedo, Sagunto
2018-07-18
Active, closed
Biotronik SE & Co. KG
Observational
3,030
Alicante, Barcelona, Burgos, Donostia / San Sebastian, Madrid, Málaga, Valencia, Vigo
2018-05-14
Active, closed
Corcept Therapeutics
Phase 2
125
Alicante, Girona, Madrid, Málaga, Seville
2018-05-07
Recruiting
Octapharma
Observational
200
Alicante, Barcelona, Málaga, Palma de Mallorca, Valencia
2018-02-13
Recruiting
Spanish Breast Cancer Research Group
Observational
8,000
Pamplona, Avilés, San Cristóbal de La Laguna, A Coruña, Albacete, Alicante, Badajoz, Badalona
2018-01-18
Recruiting
Randomization of Single vs Multiple Arterial Grafts
NCT03217006Coronary Artery Disease, Heart Diseases
Weill Medical College of Cornell University
Not applicable
4,300
Alicante, Barcelona
2018-01-07
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
L'Hospitalet de Llobregat, Santiago de Compostela, Pamplona, Alicante, Barcelona, Madrid, Málaga, Seville
2017-09-22
Recruiting
Thoracic Tumours Register
NCT02941458Thoracic Tumors
Spanish Lung Cancer Group
Observational
10,000
Ferrol, Albacete, Alcoy, Alicante, Elche, Elda, Badalona, Barcelona
2016-07-21
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
5,796
A Coruña, Alicante, Badalona, Barcelona, Burgos, Castellon, Cáceres, Córdoba
2015-08
Active, closed
AstraZeneca
Phase 3
1,118
A Coruña, Alicante, Barcelona, Girona, Jaén, León, Madrid, Majadahonda
2015-07-21
Active, closed
European Polyp Surveillance Trial
NCT02319928Colorectal Neoplasms
Asociación Española de Gastroenterología
Not applicable
20,000
Alicante
2015-06
Recruiting
Manuel Monreal
Observational
120,000
A Coruña, Cee, Ferrol, Ribeira, Santiago de Compostela, Albacete, Alicante, Elche
2001-03
Rows per page Showing 1–273 of 273
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-spain/city/alicante

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 273 of those studies with a site in Alicante.

How many clinical trials are recruiting in Alicante?

135 of the 273 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 17 have not yet opened recruitment, 116 are active but closed to new participants, and 5 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Alicante), 273 studies
PhaseStudiesRecruitingShare
Phase 31094339.9%
Observational553320.1%
Phase 2542619.8%
Not applicable382313.9%
Phase 4742.6%
Phase 1/2531.8%
Phase 2/3531.8%

Most active sponsors

Lead sponsors with the most studies (Alicante)
Lead sponsorStudiesRecruiting
AstraZeneca157
Janssen Research & Development, LLC156
Fundación GECP147
Fundación EPIC104
Incyte Corporation82
MedSIR73
Sanofi72
Aula Dental Avanzada64
Novartis Pharmaceuticals63
ETOP IBCSG Partners Foundation52
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.